Picture of Collegium Pharmaceutical logo

COLL — Collegium Pharmaceutical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Collegium Reports Fourth Quarter And Full-Year 2022 Financial Results

Feb 23 (Reuters) - Collegium Pharmaceutical Inc
 COLL.O :
    * COLLEGIUM REPORTS FOURTH QUARTER AND FULL-YEAR 2022
FINANCIAL
RESULTS
    * REAFFIRMED 2023 FINANCIAL GUIDANCE
    * GENERATED QUARTERLY NET REVENUE OF $129.6 MILLION
    * QQ4 GAAP NET LOSS WAS $7.2 MILLION, WITH $0.21 GAAP LOSS
PER
SHARE (BASIC AND DILUTED)
    * Q4 EARNINGS PER SHARE VIEW $-0.15, REVENUE VIEW $125.2
MILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7Fs8c5 
Further company coverage:  COLL.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Collegium Pharmaceutical

See all news